title: Amniocentesis and chorionic villus sampling for prenatal diagnosis.
abstract: BACKGROUND
  A major disadvantage of second trimester amniocentesis is that the result is usually available only after 18 weeks' gestation. Chorionic villus sampling (CVS) and early amniocentesis can be done between 9 and 14 weeks and offer an earlier alternative.
  
  
  OBJECTIVE
  The objective was to assess comparative safety and accuracy of second trimester amniocentesis, early amniocentesis, transcervical and transabdominal CVS.
  
  
  METHODS
  We searched the Cochrane Pregnancy and Childbirth Group trials register (March 2003) and the Cochrane Central Register of Controlled Trials (The Cochrane Library, Issue 1, 2002).
  
  
  METHODS
  All randomised trials comparing amniocentesis and CVS.
  
  
  METHODS
  Two reviewers assessed eligibility and trial quality and performed data extraction. We analysed the data using RevMan software.
  
  
  RESULTS
  A total of 14 randomised studies have been included. In a low risk population with a background pregnancy loss of around 2%, a second trimester amniocentesis will increase this risk by another 1%. This difference did not reach statistical significance, but the increase in spontaneous miscarriages following second trimester amniocentesis compared with controls (no amniocentesis) did (2.1% versus 1.3%; relative risk (RR) 1.02 to 2.52). Early amniocentesis is not a safe early alternative to second trimester amniocentesis because of increased pregnancy loss (7.6% versus 5.9%; RR 1.29, 95% CI 1.03 to 1.61) and higher incidence of talipes compared to CVS (1.8% versus 0.2%; RR 6.43, 95% CI 1.68 to 24.64).Compared with second trimester amniocentesis, transcervical CVS carries a significantly higher risk of pregnancy loss (14.5% versus 11%; RR 1.40, 95% CI 1.09 to 1.81) and spontaneous miscarriage (12.9% versus 9.4%; RR 1.50, 95% CI 1.07 to 2.11). One study compared transabdominal CVS with second trimester amniocentesis and found no significant difference in the total pregnancy loss between the two procedures (6.3% versus 7%). Transcervical CVS is more technically demanding than transabdominal CVS with more failures to obtain sample and more multiple insertions.
  
  
  CONCLUSIONS
  Second trimester amniocentesis is safer than transcervical CVS and early amniocentesis. If earlier diagnosis is required, transabdominal CVS is preferable to early amniocentesis or transcervical CVS. In circumstances where transabdominal CVS may be technically difficult the preferred options are transcervical CVS in the first trimester or second trimester amniocentesis.
authors.affiliation: Department of Obstetrics and Gynaecology, University of Liverpool, Liverpool, UK, L69 3BX.
authors.forename: Z
authors.initials: Z
authors.lastname: Alfirevic
authors.forename: K
authors.initials: K
authors.lastname: Sundberg
authors.forename: S
authors.initials: S
authors.lastname: Brigham
mesh_terms: D000649:Amniocentesis / Q000009:adverse effects* / Q000592:standards; D015193:Chorionic Villi Sampling / Q000009:adverse effects* / Q000592:standards; D000013:Congenital Abnormalities / Q000175:diagnosis; D005260:Female; D006801:Humans; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D016032:Randomized Controlled Trials as Topic